3B21.0ICD-11 MMS 2026-01
Haemorrhage due to thrombin inhibitor other than heparin
Description
A disease caused by any thrombin inhibitors other than heparin that affects normal coagulation of the blood. This disease is characterised by inability of the blood to coagulate leading to bleeding. Confirmation is by identification of thrombin inhibitors in a blood sample.
Index terms
- Haemorrhage due to thrombin inhibitor other than heparin
Exclusions from above levels
QC48.0– long-term use of anticoagulants without haemorrhageKA8F.0– vitamin K deficiency of newbornJA43.3– Postpartum coagulation defects
Show allHide
04– Diseases of the immune system05– Endocrine, nutritional or metabolic diseases18– Complications of pregnancy, childbirth or the puerperium19– Certain conditions originating in the perinatal period20– Congenital malformations, deformations or chromosomal abnormalities22– Injury, poisoning or certain other consequences of external causes- http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
JB64.1– Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium
Sibling codes
Foundation entity
Haemorrhage due to thrombin inhibitor other than heparin – http://id.who.int/icd/entity/836204111
Part of: 3B21: Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors › 03: Diseases of the blood or blood-forming organs